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Abstract
Introduction: The sole stenting technique has emerged as a new tool for the management of intracranial
aneurysms. However, several concerns have emerged about the long-term behavior of intracranial stents,
particularly their safety and efficacy.
Case presentation: We present the first case of an intracranial aneurysm intentionally treated with the sole
stenting technique. After ten years of clinical and imaging follow-up, the lesion has healed and no intrastent
stenosis is observed.
Several issues concerning this technique are discussed. For instance, the modification of the angle and intra-aneur-
ysmal thrombosis may account as positive effects; negative outcomes include in-stent thrombosis or stenosis.
Conclusions: This case report, involving a long clinical and imaging follow-up, provides an example of the
effectiveness, safety, durability and simplicity of the sole stenting technique in the management of intracranial
aneurysms.
Introduction
Giant aneurysms of the posterior circulation are uncom-
mon. However, they have a high incidence of morbidity
and mortality. The sole stenting of intracranial aneur-
ysms has been recently introduced in the armamentar-
ium of their management [1,2] and is backed up by
experimental and clinical studies [3-5]. This suggests
that the intra-aneurysmal flow is shifted by the place-
ment of a stent within the parent vessel.
Case presentation
A 43-year-old Mexican Hispanic man arrived in our
hospital with a chronic headache. His neurological
examination was unremarkable. The imaging workup
showed a giant basilar artery aneurysm, dimensions
32 mm × 20 mm (Figure 1A), and that the lesion was
located at an angled portion of the vessel. For the
management of this aneurysm, we decided to place a
stent at the aneurysm neck in order to: 1) straighten
the shape of the parent vessel; 2) promote a shift in
the pattern of the inflow into the sac and the outflow
from the lesion; and 3) foster the thrombosis of the
aneurysm.
The lesion was reached through a left vertebral
approach with a 6F guiding catheter (Envoy, Cordis,
Miami Lakes, FL). The medical periprocedural
management at that time (1997) was empirical, as no
rules for anticoagulation or antiplatelet treatment had
been defined for intracranial stents. The vascular
neurologist advised that the patient be placed under
full anticoagulation without any antiplatelet drug. A
3.5 mm × 12 mm balloon-expandable stent (BES)
(AVE Medtronic; Advanced Vascular Engineering,
Santa Rosa, CA) was advanced and deployed at the
neck of the lesion (Figures 1B, C).
When trying to retrieve the balloon, the stent slipped
backwards and its distal end tilted towards the sac.
(Figures 1C, D). We therefore decided to carefully slip
the stent forward into the aneurysm by inflating the bal-
loon again and pushing the stent distally until the whole
of it was floating within the aneurysm (Figures 1E, F). A
3.5 mm × 18 mm BES was advanced into the lesion and
subsequently deployed within the parent artery to cover
the full length of the diseased portion of the vessel,
including the aneurysm neck (Figure 1G) In the
immediate post-procedural angiographic runs, we
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observed a sluggish intra-aneurysmal vortex motion and
a correction of the shape of the parent vessel to a 45-
degree angle was conducted. The neurological status of
the patient was unchanged and he was then discharged
to the neurosurgical ward.
A control digital subtraction angiography (DSA) per-
formed four hours later to counter clinical deterioration
showed thrombosis of the aneurysm along the basilar
artery (Figure 1H). Rapid recanalization of the vessel
was obtained through a mechanical procedure (balloon
angioplasty) with the use of antiplatelet treatment (ticlo-
pidine 250 mg and aspirin 100 mg) (Figure 1I). The
patient subsequently recovered and this episode left a
pontine stroke as a sequela (Figure 1J).
At ten years after the operation, the patient has a
minor paresis, with a modified Rankin Scale of 2. A new
imaging follow-up with DSA and three-dimensional
reconstruction has been performed, which showed that
the aneurysm remains occluded (no recanalization), the
parent vessel is still patent, and no in-stent stenosis is
present (Figure 2C to 2F). The clinical evolution of the
patient is described in Table 1.
Discussion
Complex aneurysms of the posterior circulation are
uncommon. Nevertheless, their surgical and endovascu-
lar management represents a challenge because their
incidences of morbidity and mortality are high. Giant
aneurysms are dynamic lesions with intraluminal
thrombus formation, occasionally giving rise to throm-
boembolic events [6]. Other methods have also been
described, such as medical management with anticoagu-
lants and surgical options like by-pass surgery [6,7], and
interventional procedures have become widely accepted
and stand as the first option in many cases, especially in
posterior circulation giant aneurysms.
The use of stents as an ancillary tool in the manage-
ment of wide neck intracranial aneurysms with coils
Figure 1 Imaging of the aneurysm before (A), during the stenting (B-G) and in vascular rescue procedure (H-J). A) Preoperative angio-
CT: Aneurysm of the basilar artery (hollow arrow) and evidence of wide neck (thin arrows). B) to G) First procedure. A balloon-expandable stent
(arrowhead in B and thick arrow in C) is advanced on a microguidewire (thin arrows in B). Once the stent was deployed, it slid out of place towards
the sac (thick arrows in D). The whole misplaced stent was gently pushed into the sac (thick arrow in E and F) using a balloon mounted on the same
microguidewire (thin arrows in E). A second balloon-expandable stent (arrowhead in F) is placed over the entire length of this wide-necked aneurysm
(hollow arrow in F). This second balloon-expandable stent is in a correct position within the parent vessel (dotted arrow in G), the first misplaced BES
lies within the aneurysm (thick arrow in G) and a sluggish intraaneurysmal vortex motion is clearly shown (hollow arrow in G). Second procedure.
Neurological impairment four hours later explained by in-stent thrombosis. An intravascular clot initially emerging from the thrombosing sac (hollow
arrow in H) overflows into the basilar artery (dotted arrow in H). Both pharmacological and mechanical measures using a microguidewire (thin arrows
in J) successfully recanalize the arterial tree distal to the aneurysm (J). Imaging follow-up. At one week, the T1 magnetic resonance imaging shows a
residual stroke in the ventral portion of the cerebral peduncle (dotted arrow in K).
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started in 1997. The technique aims to build an artificial
neck to the aneurysm, thus preventing the occlusion of
the parent vessels by coils bulging into the lumen [8].
Furthermore, the stent promotes the redirection of the
flow away from the aneurysm, increasing the rate of
complete embolization and decreasing the rate of reca-
nalization [8,9]. Both in vitro and computerized models
of aneurysms treated by stent placement without coiling
have shown that this device promotes the redirection of
the bloodstream away from the aneurysm, which pro-
duces a sluggish intra-aneurysmal vortex motion with
subsequent blood stasis [10]. In animal models, the
stents have shown their ability to induce the permanent
occlusion of the aneurysms due to an intra-aneurysmal
thrombosis, which may be explained by the aforemen-
tioned hemodynamical modifications. Another thrombo-
sis-inducing effect is the ability to change the flow
pattern within the aneurysmal sac from a helical into a
noncoherent turbulence capable of inducing thrombosis
[3,11]. Additionally, after the aneurysm has thrombosed,
the luminar surface of the stent is covered with neoin-
tima and the treated arterial segment is remodeled.
The sole stenting technique has also been applied in
humans. Our initial experience in a prospective series of
20 cases has yielded encouraging results [3], as this
technique promotes the healing of the aneurysm and
provides a certain protection against further rupture.
We have stressed the safety and the effectiveness of this
technique in posterior circulation aneurysms [3,12]. Still,
the placement of an intracranial stent encompasses
some possible complications. However, the development
of new devices, such as BES and self-expandable stents
(SES), has decreased the incidence of technical compli-
cations like arterial dissection [5,9]. The acute
Figure 2 Imaging follow-up spanning ten years. A) Imaging at three months. Angio-CT reconstruction shows the first (thick arrow) and the
second (dotted arrow) with a dog-ear residual sac (thin arrow). B) One year imaging. Digital Subtraction Angiography showing complete healing
of the aneurysm (B). No in-stent stenosis. No recanalization. C) to F): Ten years imaging. Control Digital Subtraction Angiography runs (C and D)
show no aneurysm and a patent stented vessel. The misplaced intra-aneurysmal extravascular stent is shown as well (thin arrow in D). Three-
dimensional reconstruction (E and F) confirms these findings, with a nice visualization of both stents in dual reconstruction (dotted and thick
arrows in E). No in-stent stenosis. No recanalization.
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thrombosis of the device is also highly uncommon due
to routinely administered antiplatelet medication in any
stent deployment.
In our case, the in-stent thrombosis occurred due to
an inadequate antiplatelet regime [1,3]. Han et al. have
reported the case of a patient with in-stent thrombosis
in a series of 10 complex aneurysms treated by stent-
assisted coiling (BES) [14]. In a series of 48 intracranial
aneurysms managed with SES, thromboembolic events
occurred in a total of six cases, of which four happened
when the mesh was crossing the stent with the coils [9].
An intrarterial or intravenous infusion of a glycoprotein
IIb-IIIa inhibitor (abciximab) resolved this complication
in most of cases. In a series of 74 aneurysms, most of
them treated by stent-supported coiling, Fiorella et al.
reported six symptomatic thromboembolic complica-
tions, wherein one of them had a late in-stent thrombo-
sis by discontinuation of antiplatelet drugs [8]. On the
other hand, in our prospective series of 20 complex
aneurysms of the posterior circulation managed by the
sole stenting technique, we encountered no intrastent
thrombosis [3]. However, in analyzing our series of
more than 200 aneurysms treated using an intracranial
stent (either sole stenting or stent-assisted coiling), a
thrombosis within the stent has been observed in about
10% of cases, all of them using SES. This complication
has never occurred with a BES, except in the case pre-
sented in this report. As opposed to Fiorella et al. [8],
we think that the low radial force of the SES may lead
to poor wall apposition of the stent, which may cause a
thrombogenic process.
In order to avoid in-stent acute thrombosis we
designed a protocol that has been recently published
and discussed [15]. This protocol pertains to the fol-
lowing: 1) In unruptured aneurysms, either a double
regime (clopidogrel, 75 mg qd and acetylsalicylic acid,
100 mg qd) is started at least four days before the
procedure, or a loading dose of 300 mg of clopidogrel
is given four hours before the procedure; 2) In rup-
tured aneurysms, intravenous antiplatelet regime is
started during the deployment of the stent. In all
cases, the patient is kept under antiplatelet drugs
using oral medication (clopidogrel, 75 mg qd and
acetylsalicylic acid, 100 mg qd) and one additional
drug (usually aspirin) for the next six months. When a
neurosurgical procedure is foreseeable, we suggest: a)
If hydrocephalus shunting or hematoma removal is
likely, the patient should be excluded from a stenting
procedure to avoid perioperative bleeding; b) If mod-
erate hydrocephalus is present with Fisher III-IV,
either do not to place a stent at all or place the shunt
before the stent; c) When the likelihood of being
operated is remote but is still probable, another option
is to keep the patient on an intravenous antiplatelet
regime (tirofiban) for three days. In case necessary,
the discontinuation of tirofiban will allow a surgery
four hours thereafter. This is not the case with oral
antiplatelet drugs (clopidogrel and ticlopidine act on
ADP and aspirin act on thromboxane-A2). Both of
them require seven days of discontinued use of abcixi-
mab (which acts on fibrinogen cross-linking) and 48
hours of discontinued administration of antiplatelet
drugs in order to ensure a safe surgery.
Another feared complication after intravascular stent-
ing is the development of intimal hyperplasia leading to
an in-stent stenosis. In coronary stenting for athero-
sclerosis, this occurs in up to 50% of reported cases. In
intracranial atherosclerosis, the rate of restenosis may be
present in up to 40% of cases [16]. Nonetheless, the use
of intracranial stents in aneurysm raises a different
issue: Han et al. found no stenosis in a series of 10
cases treated with a BES [14], and Lylyk et al. found no
in-stent stenosis in 29 cases (SES) during a median fol-
low-up period of 7.3 months [9,17]. In another series,
Fiorella et al. reported an in-stent stenosis in 3.8% of 74
treated cases of aneurysms (SES) [8]. In this article, the
authors state that, although the true incidence of clini-
cally relevant in-stent stenosis after Neuroform stenting
would not be clear until a larger volume of follow-up
data become available, the lack of any similar reports
would suggest that this occurrence is likely to be rela-
tively rare. In our series, we encountered only one case
of lumen reduction due to intimal hyperplasia (the
patient had a severe dyslipidemia). This finding was
asymptomatic and healed at 12 months under medical
treatment (statins) [3]. We are not oblivious to the fact
that this patient is only one case. However, this case is
highly significant by its unique ten-year follow-up and
shows that intracranial stenting may be safe and effica-
cious in the long run.
Conclusions
To our knowledge, this is the first case where the sole
stenting technique was employed. Even if the presence
of another stent within the aneurysm might have
favored the thrombosis of the lesion (foreign body),
both the correction of the angle and the hemodynami-
cal changes were present right from the beginning of
the whole process. The intraaneurysmal coils act as a
foreign body. However, they do not in any way pre-
vent recanalization. Even if ours is only one case, this
exceptionally prolonged reported follow-up of ten
years provides a superb and palpable example of the
effectiveness, safety, durability and simplicity of the
sole stenting in the management of intracranial aneur-
ysms, preventing the recanalization of the lesion with-
out the alleged long-term danger of in-stent
restenosis.
Zenteno et al. Journal of Medical Case Reports 2010, 4:64
http://www.jmedicalcasereports.com/content/4/1/64
Page 4 of 5
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompany-
ing images. A copy of the written consent is available
for review by the Editor-in-Chief of this journal.
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